Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials.

Heather L ThompsonJane GrabowskiBarbara FranklinKimberley S KoetsierD Bradley Welling

Published in: Clinical trials (London, England) (2024)

Response Evaluation in Neurofibromatosis and Schwannomatosis currently recommends the Tinnitus Functional Index for the assessment of tinnitus in neurofibromatosis type 2 clinical trials.

Keyphrases

clinical trial
patient reported
hearing loss
phase ii
open label
study protocol
randomized controlled trial
clinical practice
drug induced